Who Supplies Carboplatin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Carboplatin exports, with 273+ registered manufacturers shipping to buyers across 138+ countries — yet a handful of companies dominate the shipments. FRESENIUS KABI ONCOLOGY LIMITED holds the largest share at 20.0% (export value: $14.1M). Close behind, EUGIA PHARMA SPECIALITIES LIMITED (8.7%, $6.2M). GLAND PHARMA LIMITED (6.0%, $4.3M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Carboplatin? Top Manufacturers & Their Buyers
Flow of Carboplatin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Carboplatin Supplier Network — Key Market Intelligence
The Carboplatin export market from India is led by FRESENIUS KABI ONCOLOGY LIMITED, which alone commands a 20.0% share, shipping $14.1M worth of product across 735 shipments. The second-largest exporter, EUGIA PHARMA SPECIALITIES LIMITED, contributes $6.2M (8.7%) to the overall market. Combined, the top two suppliers alone account for 28.7% of all Carboplatin exports, indicating a relatively concentrated supply base.
Across all 273 tracked manufacturers, the total Carboplatin export value stands at $70.9M from 3.6K shipments. The market average shipment value is $19.5K. The single largest buyer relationship in terms of trade value is FRESENIUS KABI DEUTSCHLAND GMBH, receiving $11.5M worth of product.
The combined buyer network spans 23 named purchasing companies, including FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI COLOMBIA SAS, FRESENIUS KABI THAILAND LTD, FRESENIUS KABI MALAYSIA SDN BHD, EUGIA US LLC, and 18 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1FRESENIUS KABI ONCOLOGY LIMITED
FRESENIUS KABI ONCOLOGY LIMITED is the first-largest Carboplatin exporter from India, with a market share of 20.0% and a total export value of $14.1M across 735 shipments. Their average shipment value of $19.3K is below the market average of $19.5K, reflecting a high-volume, competitive pricing strategy.
FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. FRESENIUS KABI DEUTSCHLAND GMBH is the dominant customer, accounting for 81.5% of this supplier's tracked business. Top customers include:
• FRESENIUS KABI DEUTSCHLAND GMBH — $11.5M across 599 shipments (81.5% of this supplier's total exports)
• FRESENIUS KABI COLOMBIA SAS — $750.8K across 39 shipments (5.3% of this supplier's total exports)
• FRESENIUS KABI THAILAND LTD — $651.7K across 34 shipments (4.6% of this supplier's total exports)
• FRESENIUS KABI THAILAND LTD — $613.0K across 32 shipments (4.3% of this supplier's total exports)
• FRESENIUS KABI MALAYSIA SDN BHD — $602.6K across 31 shipments (4.3% of this supplier's total exports)
Key Insight: FRESENIUS KABI ONCOLOGY LIMITED operates with high shipment frequency (735 shipments) at a per-shipment value of $19.3K, indicating a broad distribution network with many smaller, regular orders.
2EUGIA PHARMA SPECIALITIES LIMITED
EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Carboplatin exporter from India, with a market share of 8.7% and a total export value of $6.2M across 66 shipments. Their average shipment value of $93.9K is above the market average of $19.5K, suggesting premium or bulk contract pricing.
EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. EUGIA US LLC, is the dominant customer, accounting for 50.7% of this supplier's tracked business. Top customers include:
• EUGIA US LLC, — $3.1M across 33 shipments (50.7% of this supplier's total exports)
• EUGIA US LLC, — $2.9M across 31 shipments (46.7% of this supplier's total exports)
• AUROVIDA FARMACEUTIC — $103.2K across 1 shipments (1.7% of this supplier's total exports)
• EUGAIA PHARMA SPECIA — $41.6K across 0 shipments (0.7% of this supplier's total exports)
• APL SWIFT SERVICES ( — $14.8K across 0 shipments (0.2% of this supplier's total exports)
Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $93.9K is 382% above the market average of $19.5K, consistent with large-order contracts or value-added formulations.
3GLAND PHARMA LIMITED
GLAND PHARMA LIMITED is the third-largest Carboplatin exporter from India, with a market share of 6.0% and a total export value of $4.3M across 10 shipments. Their average shipment value of $426.6K is above the market average of $19.5K, suggesting premium or bulk contract pricing.
GLAND PHARMA LIMITED serves 3 named buyers in our database. CHRIS LESSLY is the dominant customer, accounting for 57.9% of this supplier's tracked business. Top customers include:
• CHRIS LESSLY — $2.5M across 6 shipments (57.9% of this supplier's total exports)
• XXI LXXS LXX — $1.3M across 3 shipments (30.2% of this supplier's total exports)
• Nicole Salvi — $509.3K across 1 shipments (11.9% of this supplier's total exports)
Key Insight: GLAND PHARMA LIMITED's per-shipment value of $426.6K is 2088% above the market average of $19.5K, consistent with large-order contracts or value-added formulations.
4NV REMEDIES PRIVATE LIMITED
NV REMEDIES PRIVATE LIMITED is the fourth-largest Carboplatin exporter from India, with a market share of 4.1% and a total export value of $2.9M across 11 shipments. Their average shipment value of $264.4K is above the market average of $19.5K, suggesting premium or bulk contract pricing.
NV REMEDIES PRIVATE LIMITED serves 4 named buyers in our database. CPC "BIOCON" LLC is the dominant customer, accounting for 71.0% of this supplier's tracked business. Top customers include:
• CPC "BIOCON" LLC — $2.1M across 8 shipments (71.0% of this supplier's total exports)
• CPC "BIOCON" LLC — $817.5K across 3 shipments (28.1% of this supplier's total exports)
• CENTRE NATIONAL DE L — $26.7K across 0 shipments (0.9% of this supplier's total exports)
• MILI HEALTHCARE LTD — $21 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: NV REMEDIES PRIVATE LIMITED's per-shipment value of $264.4K is 1256% above the market average of $19.5K, consistent with large-order contracts or value-added formulations.
5INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the fifth-largest Carboplatin exporter from India, with a market share of 3.2% and a total export value of $2.3M across 190 shipments. Their average shipment value of $11.9K is below the market average of $19.5K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• XXCORXXHEAXXHCAXX INXX — $565.7K across 48 shipments (25.1% of this supplier's total exports)
• TO THE ORDER — $530.0K across 45 shipments (23.5% of this supplier's total exports)
• ACCORD HEALTHCARE INC — $401.2K across 34 shipments (17.8% of this supplier's total exports)
• XXCORXXHEAXXHCAXX LT — $380.4K across 32 shipments (16.9% of this supplier's total exports)
• ACCORD HEALTHCARE LI — $379.8K across 32 shipments (16.8% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (190 shipments) at a per-shipment value of $11.9K, indicating a broad distribution network with many smaller, regular orders.
6VENUS REMEDIES LIMITED
VENUS REMEDIES LIMITED is the fifth-largest Carboplatin exporter from India, with a market share of 1.9% and a total export value of $1.4M across 123 shipments. Their average shipment value of $11.0K is below the market average of $19.5K, reflecting a high-volume, competitive pricing strategy.
VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• E M I — $544.1K across 49 shipments (40.2% of this supplier's total exports)
• A.S.A.S — $460.7K across 42 shipments (34.0% of this supplier's total exports)
• IMS PHARMA PNA — $144.2K across 13 shipments (10.6% of this supplier's total exports)
• B P D & C C — $112.1K across 10 shipments (8.3% of this supplier's total exports)
• A S A S ALPHARMA SAS — $92.8K across 8 shipments (6.9% of this supplier's total exports)
Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (123 shipments) at a per-shipment value of $11.0K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Carboplatin Flows
Once Carboplatin leaves the manufacturing plants of companies like FRESENIUS KABI ONCOLOGY LIMITED and EUGIA PHARMA SPECIALITIES LIMITED, it travels to 5 destination markets with a combined import value of $70.9M. Germany absorbs the largest share at 22.6% ($16.0M), followed by United States (17.1%) and Thailand (6.8%).
In Germany — the top destination — named importers include FRESENIUS KABI DEUTSCHLAND GMBH. In United States, key buyers are EUGIA US LLC, EUGIA US LLC,, CHRIS LESSLY.
This geographic spread reflects Carboplatin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Carboplatin Go? Top Importing Countries & Their Buyers
Trade flow of Carboplatin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Germany
Germany ranks as the first-largest destination for Carboplatin imports from India, with a total trade value of $16.0M across 391 shipments — representing a 22.6% share of all Carboplatin exports. The average shipment value of $40.9K is above the global average of $19.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Carboplatin importers in Germany: FRESENIUS KABI DEUTSCHLAND GMBH is the largest buyer, accounting for 99.3% ($15.9M) of this market's total imports.
• FRESENIUS KABI DEUTSCHLAND GMBH — $15.9M (99.3% of Germany's total)
Key Insight: Germany's per-shipment average of $40.9K (110% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Carboplatin imports from India.
2United States
United States ranks as the second-largest destination for Carboplatin imports from India, with a total trade value of $12.2M across 65 shipments — representing a 17.1% share of all Carboplatin exports. The average shipment value of $187.0K is above the global average of $19.5K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Carboplatin importers in United States: EUGIA US LLC is the largest buyer, accounting for 27.8% ($3.4M) of this market's total imports.
• EUGIA US LLC — $3.4M (27.8% of United States's total)
• EUGIA US LLC, — $3.3M (27.0% of United States's total)
• CHRIS LESSLY — $2.5M (20.3% of United States's total)
Key Insight: United States's per-shipment average of $187.0K (859% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Carboplatin imports from India.
3Thailand
Thailand ranks as the third-largest destination for Carboplatin imports from India, with a total trade value of $4.8M across 24 shipments — representing a 6.8% share of all Carboplatin exports. The average shipment value of $199.5K is above the global average of $19.5K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Carboplatin importers in Thailand: FRESENIUS KABI (THAILAND) LTD is the largest buyer, accounting for 23.6% ($1.1M) of this market's total imports.
• FRESENIUS KABI (THAILAND) LTD — $1.1M (23.6% of Thailand's total)
• FRESENIUS KABI (THAILAND) LTD., — $701.9K (14.7% of Thailand's total)
• FRESENIUS KABI THAILAND LTD — $651.7K (13.6% of Thailand's total)
Key Insight: Thailand's per-shipment average of $199.5K (923% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Thailand is a key market for Carboplatin imports from India.
4Philippines
Philippines ranks as the fourth-largest destination for Carboplatin imports from India, with a total trade value of $3.2M across 16 shipments — representing a 4.6% share of all Carboplatin exports. The average shipment value of $202.7K is above the global average of $19.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Carboplatin importers in Philippines: MULTICARE PHARMACEUTICALS PHILIPPIN is the largest buyer, accounting for 24.3% ($786.8K) of this market's total imports.
• MULTICARE PHARMACEUTICALS PHILIPPIN — $786.8K (24.3% of Philippines's total)
Key Insight: Philippines's per-shipment average of $202.7K (940% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Carboplatin imports from India.
5Ukraine
Ukraine ranks as the fifth-largest destination for Carboplatin imports from India, with a total trade value of $2.9M across 7 shipments — representing a 4.1% share of all Carboplatin exports. The average shipment value of $415.7K is above the global average of $19.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Carboplatin importers in Ukraine: CPC "BIOCON" LLC is the largest buyer, accounting for 70.9% ($2.1M) of this market's total imports.
• CPC "BIOCON" LLC — $2.1M (70.9% of Ukraine's total)
• CPC BIOCON LLC — $817.5K (28.1% of Ukraine's total)
Key Insight: Ukraine's per-shipment average of $415.7K (2032% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ukraine is a key market for Carboplatin imports from India.
People Also Ask — Carboplatin Supplier & Trade Network
Who are the top suppliers of Carboplatin from India?+
Which companies buy Carboplatin from Indian manufacturers?+
Where does Carboplatin exported from India go?+
What is the market share of the top Carboplatin supplier from India?+
What is the average shipment value for Carboplatin exports from India?+
Is Carboplatin manufactured in India and exported globally?+
Which country imports the most Carboplatin from India?+
Who are the buyers of Carboplatin in United States?+
How concentrated is the Carboplatin supplier market in India?+
How do I find verified buyers for Carboplatin in specific countries?+
Carboplatin Trade Network — Key Takeaways
- 1FRESENIUS KABI ONCOLOGY LIMITED is India's dominant Carboplatin exporter with a 20.0% market share and $14.1M in total exports — making it the single most important sourcing entity in this market.
- 2The top 273 suppliers collectively account for 43.9% of all tracked Carboplatin exports, with a combined trade value of $70.9M.
- 3Germany is the largest destination market, absorbing 22.6% of India's Carboplatin exports ($16.0M). United States (17.1%) and Thailand (6.8%) follow.
- 4With 3.6K total shipments averaging $19.5K each, the Carboplatin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI COLOMBIA SAS, EUGIA US LLC,, EUGIA US LLC, — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 138 countries
Network value: $70.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Carboplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Carboplatin.
- 2.Flow Mapping: 273 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,637 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 138 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,637 Verified Shipments
273 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists